SERPINC1 and COVID-19: Furthermore, acquired deficiency of the natural inhibitors of coagulation like Protein C (PC), Protein S (PS), antithrombin III (ATIII) could be explored as a possible contributor to the hypercoagulable state of the COVID-19 patients, their value in the prognosis and as a replacement therapy is also controversial [17–22].